Genetic analysis of high-risk Utah suicide pedigrees
犹他州高风险自杀家系的遗传分析
基本信息
- 批准号:9033440
- 负责人:
- 金额:$ 15.53万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2013
- 资助国家:美国
- 起止时间:2013-08-01 至 2016-05-31
- 项目状态:已结题
- 来源:
- 关键词:AccountingAgeBiologicalCause of DeathCessation of lifeCharacteristicsCollaborationsCommunitiesDNADataData AggregationData SetDatabasesDetectionDideoxy Chain Termination DNA SequencingDiscriminationDiseaseEnvironmentEpidemiologic StudiesExhibitsFamilyFosteringFutureGenderGene Expression RegulationGenealogyGenesGenetic ResearchGenetic RiskGenetic VariationGenomeGenotypeHandHealthHeritabilityIndividualKnowledgeLightLinkMedicalMedical ExaminersMethodsMolecularPathway interactionsPhenotypePopulationPopulation DatabasePromoter RegionsRecordsRelative (related person)ResourcesRiskRisk FactorsSamplingSourceSuicideSuicide attemptTestingUnited StatesUnited States National Center for Health StatisticsUtahValidationVariantWorld Health Organizationaccomplished suicideanalytical methodcohortcomputerizeddemographicsexomeexome sequencingfollow-upgenetic analysisgenetic pedigreegenetic risk factorgenetic variantgenome sequencinghigh riskinterestmalenon-geneticpopulation basedpsychogeneticspublic health relevancerare variantsuicidal morbiditysuicidal risksuicide ratetool
项目摘要
DESCRIPTION (provided by applicant): Suicide is a significant health concern. There are over 33,000 suicide deaths per year in the United States, accounting for 1.3% of all fatalities (WISQARS, 2005), and about 2% of deaths worldwide (World Health Organization, 2000). Aggregated data across multiple large studies has produced heritability estimates of completed suicide of 45%. The Rocky Mountain States have much higher age-adjusted suicide rates, and Utah is consistently in the top ten. In Utah, suicide is the leading cause of death for males between the ages of 15 and 54. Our project will use a large DNA resource already collected from decedents through a long-term collaboration with the centralized Utah State Office of the Medical Examiner (OME). Records of >2,000 decedents with DNA were linked to the Utah Population DataBase (UPDB), a computerized genealogy database that includes medical data, demographic information, and genealogical data for over 6.5 million individuals. Using the UPDB, we identified 27 high risk families containing ~150 suicide decedents with DNA. As a rare condition (1-2/10,000 per year), aggregation of suicide completion in high-risk pedigrees represents a unique resource to study risk factors. We will use the genealogical, demographic, and medical data in the UPDB to identify and focus on the most compelling of these high-risk suicide pedigrees; those that contain both a significant excess of suicide completion and that exhibit the most discriminating characteristics compared to non-familial suicide. By using these phenotypic comparisons to choose the most unique high-risk pedigrees, we will increase homogeneity and strengthen our ability to isolate genetic variants related to suicide risk. These discriminating phenotypes will also identify non-genetic factors associated with high familial risk
that can foster other epidemiological studies, and can facilitate future gene x environment analyses. We currently have in hand a large resource of DNA and phenotype information from ~2500 additional Utah suicide decedents. This sample will grow to over 4000 DNAs by the end of the study, the largest population-based sample of DNA from suicide decedents ever collected. We propose to focus on unusual high-risk suicide pedigrees with increased likelihood for more penetrant rare genetic variation, followed by confirmation and follow-up analyses in large cohorts of Utah decedents and publicly-available psychiatric data sets. The detection of genetic variants associated with suicide could shed light on biological pathways leading to suicide risk in the population, or in association with specific disorders. We have chosen state-of-the-art analytical methods, and have assembled a team of experts (analytic, phenotypic, and molecular) to explore these unique data resources to identify genetic risk factors for suicide. The
detection of rare variants associated with suicide could shed light on biological pathways leading to suicide risk in the population, or in association with specific disorders.
描述(由申请人提供):自杀是一个重大的健康问题。美国每年有超过 33,000 人自杀死亡,占所有死亡人数的 1.3%(WISQARS,2005 年),约占全世界死亡人数的 2%(世界卫生组织,2000 年)。多项大型研究的汇总数据得出自杀完成率的遗传性估计为 45%。落基山脉各州的年龄调整自杀率要高得多,而犹他州一直位居前十。在犹他州,自杀是 15 岁至 54 岁男性死亡的主要原因。我们的项目将使用通过与犹他州集中体检办公室 (OME) 长期合作从死者那里收集的大量 DNA 资源。 )。超过 2,000 名带有 DNA 的死者记录与犹他州人口数据库 (UPDB) 相关联,这是一个计算机化的家谱数据库,其中包括超过 650 万人的医疗数据、人口统计信息和家谱数据。使用 UPDB,我们确定了 27 个高风险家庭,其中包含约 150 名带有 DNA 的自杀死者。作为一种罕见的情况(每年 1-2/10,000 例),高风险谱系中自杀完成情况的汇总代表了研究风险因素的独特资源。我们将使用 UPDB 中的家谱、人口统计和医学数据来识别并关注这些高风险自杀谱系中最引人注目的一个;与非家庭自杀相比,那些自杀完成率显着过高且表现出最具区别性特征的自杀者。通过使用这些表型比较来选择最独特的高风险谱系,我们将增加同质性并增强我们分离与自杀风险相关的遗传变异的能力。这些区分表型还将识别与高家族风险相关的非遗传因素
这可以促进其他流行病学研究,并可以促进未来的基因 x 环境分析。目前,我们手头有来自约 2500 名犹他州自杀死者的大量 DNA 和表型信息。到研究结束时,该样本将增加到超过 4000 个 DNA,这是迄今为止从自杀者死者中收集的最大的基于人群的 DNA 样本。我们建议重点关注不寻常的高风险自杀谱系,这些谱系出现更具渗透性的罕见遗传变异的可能性更大,然后对犹他州死者的大型队列和公开的精神病学数据集进行确认和后续分析。检测与自杀相关的遗传变异可以揭示导致人群自杀风险或与特定疾病相关的生物学途径。我们选择了最先进的分析方法,并组建了一个专家团队(分析、表型和分子)来探索这些独特的数据资源,以确定自杀的遗传风险因素。这
检测与自杀相关的罕见变异可以揭示导致人群自杀风险或与特定疾病相关的生物学途径。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Hilary Coon其他文献
Hilary Coon的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Hilary Coon', 18)}}的其他基金
Genetic risk discovery using WGS from a population-based resource of 10,000 suicide deaths with DNA
使用全基因组测序 (WGS) 从 10,000 例自杀死亡病例的人口资源中发现遗传风险
- 批准号:
10553712 - 财政年份:2020
- 资助金额:
$ 15.53万 - 项目类别:
Prediction of suicide death using EHR and polygenic risk scores
使用 EHR 和多基因风险评分预测自杀死亡
- 批准号:
10659155 - 财政年份:2020
- 资助金额:
$ 15.53万 - 项目类别:
Genetic risk discovery using WGS from a population-based resource of 10,000 suicide deaths with DNA
使用全基因组测序 (WGS) 从 10,000 例自杀死亡病例的人口资源中发现遗传风险
- 批准号:
10337286 - 财政年份:2020
- 资助金额:
$ 15.53万 - 项目类别:
Prediction of suicide death using EHR and polygenic risk scores
使用 EHR 和多基因风险评分预测自杀死亡
- 批准号:
10027263 - 财政年份:2020
- 资助金额:
$ 15.53万 - 项目类别:
Prediction of suicide death using EHR and polygenic risk scores
使用 EHR 和多基因风险评分预测自杀死亡
- 批准号:
10239191 - 财政年份:2020
- 资助金额:
$ 15.53万 - 项目类别:
Prediction of suicide death using EHR and polygenic risk scores
使用 EHR 和多基因风险评分预测自杀死亡
- 批准号:
10451573 - 财政年份:2020
- 资助金额:
$ 15.53万 - 项目类别:
Genetic analysis of high-risk Utah suicide pedigrees
犹他州高风险自杀家系的遗传分析
- 批准号:
9114177 - 财政年份:2013
- 资助金额:
$ 15.53万 - 项目类别:
Genetic analysis of high-risk Utah suicide pedigrees
犹他州高风险自杀家系的遗传分析
- 批准号:
9275545 - 财政年份:2013
- 资助金额:
$ 15.53万 - 项目类别:
Genetic analysis of high-risk Utah suicide pedigrees
犹他州高风险自杀家系的遗传分析
- 批准号:
8850718 - 财政年份:2013
- 资助金额:
$ 15.53万 - 项目类别:
Genetic analysis of high-risk Utah suicide pedigrees
犹他州高风险自杀家系的遗传分析
- 批准号:
8575486 - 财政年份:2013
- 资助金额:
$ 15.53万 - 项目类别:
相似国自然基金
多氯联苯与机体交互作用对生物学年龄的影响及在衰老中的作用机制
- 批准号:82373667
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
开发新型可预测生物年龄和疾病风险的表观遗传和转录组分子时钟
- 批准号:32370699
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
基于生物学年龄分层的广西长寿人群的健康正性因子识别和验证
- 批准号:
- 批准年份:2022
- 资助金额:32 万元
- 项目类别:地区科学基金项目
能粘附眼表糖萼和跨越眼部生物屏障的载川芎嗪纳米胶束治疗年龄相关性黄斑变性的研究
- 批准号:82274372
- 批准年份:2022
- 资助金额:51 万元
- 项目类别:面上项目
基于堆叠式集成学习探索人居环境对生物学年龄的影响
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
An immunotherapeutic IgY formulation against norovirus diarrhea
一种针对诺如病毒腹泻的免疫治疗 IgY 制剂
- 批准号:
10693530 - 财政年份:2023
- 资助金额:
$ 15.53万 - 项目类别:
Letrozole for Treatment of Uterine Fibroids: A randomized, placebo-controlled trial
来曲唑治疗子宫肌瘤:一项随机、安慰剂对照试验
- 批准号:
10718036 - 财政年份:2023
- 资助金额:
$ 15.53万 - 项目类别:
Mentoring the next generation of substance use, HIV, and epigenetic researchers in sexual and gender minority health
指导下一代性和性别少数健康领域的药物滥用、艾滋病毒和表观遗传学研究人员
- 批准号:
10699933 - 财政年份:2023
- 资助金额:
$ 15.53万 - 项目类别:
Sensitivity to Cannabis Effects and Cue Reactivity as Markers of a Developing Disorder in Adolescents
对大麻效应的敏感性和提示反应性作为青少年发育障碍的标志
- 批准号:
10586397 - 财政年份:2023
- 资助金额:
$ 15.53万 - 项目类别:
Cognitive Decline and Incident Dementia in Older Patients with Secondary Hyperparathyroidism
继发性甲状旁腺功能亢进症老年患者的认知能力下降和痴呆
- 批准号:
10587339 - 财政年份:2023
- 资助金额:
$ 15.53万 - 项目类别: